In the group of patients receiving adjuvant chemotherapy, low expression of PD-L1 was significantly associated with RFS (p = 0.016, log-rank) (Figure 7A), and a similar trend was observed for VISTA (p = 0.12, log-rank) (Figure 7B), whereas the infiltration of rete testis, tumor size, LVI, tumor extent (pT feature), and markers of systemic inflammation did not affect the risk. The gene discussed is CD274; the disease is neoplasm.